The prevalence of Wilson’s disease is 30 per million population which has progressively increased over the recent years [3,4,5,6]. Ceruloplasmin, a copper-binding protein synthesized in the liver, is typically decreased in Wilson's disease and serves as one of the diagnostic markers. Here, CP is linked to Wilson disease.